TransEnterix Profit Margin 2006-2020 | TRXC
Current and historical gross margin, operating margin and net profit margin for TransEnterix (TRXC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. TransEnterix net profit margin as of March 31, 2020 is -2133.1%.
|TransEnterix Annual Profit Margins
|TransEnterix Quarterly Profit Margins
||Medical Instruments Manufacturing
TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.